BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32723621)

  • 1. Monitoring Plasma Cell Dyscrasias With Cell-free DNA Analysis.
    Ntanasis-Stathopoulos I; Gavriatopoulou M; Terpos E; Fotiou D; Kastritis E; Dimopoulos MA
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e905-e909. PubMed ID: 32723621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the MYD88
    Wu YY; Jia MN; Cai H; Qiu Y; Zhou DB; Li J; Cao XX
    Ann Hematol; 2020 Aug; 99(8):1763-1769. PubMed ID: 32577844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.
    Bagratuni T; Ntanasis-Stathopoulos I; Gavriatopoulou M; Mavrianou-Koutsoukou N; Liacos C; Patseas D; Kanellias N; Migkou M; Ziogas DC; Eleutherakis-Papaiakovou E; Roussou M; Fotiou D; Terpos E; Kastritis E; Dimopoulos MA
    Leukemia; 2018 Dec; 32(12):2617-2625. PubMed ID: 30026568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Highly sensitive
    Drandi D; Genuardi E; Dogliotti I; Ferrante M; Jiménez C; Guerrini F; Schirico ML; Mantoan B; Muccio V; Lia G; Zaccaria GM; Omedè P; Passera R; Orsucci L; Benevolo G; Cavallo F; Galimberti S; Sanz RG; Boccadoro M; Ladetto M; Ferrero S
    Haematologica; 2018 Jun; 103(6):1029-1037. PubMed ID: 29567768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Biopsy in Gastric Cancer: Analysis of Somatic Cancer Tissue Mutations in Plasma Cell-Free DNA for Predicting Disease State and Patient Survival.
    Varkalaite G; Forster M; Franke A; Kupcinskas J; Skieceviciene J
    Clin Transl Gastroenterol; 2021 Sep; 12(9):e00403. PubMed ID: 34644276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of Waldenström Macroglobulinemia in Korean Patients According to Mutational Status of MYD88 and CXCR4: Analysis Using Ultra-Deep Sequencing.
    Shin DW; Kim SM; Kim JA; Park HS; Hwang SM; Im K; Kim S; Kim J; Kwon S; Yoon SS; Lee DS
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):e496-e505. PubMed ID: 31221512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of clonal hematopoiesis in the interpretation of blood liquid biopsy.
    Chan HT; Nagayama S; Chin YM; Otaki M; Hayashi R; Kiyotani K; Fukunaga Y; Ueno M; Nakamura Y; Low SK
    Mol Oncol; 2020 Aug; 14(8):1719-1730. PubMed ID: 32449983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell-free DNA as a biomarker in diffuse large B-cell lymphoma: A systematic review.
    Arzuaga-Mendez J; Prieto-Fernández E; Lopez-Lopez E; Martin-Guerrero I; García-Ruiz JC; García-Orad A
    Crit Rev Oncol Hematol; 2019 Jul; 139():7-15. PubMed ID: 31112884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Driver Mutational Hot Spots in Blood-Derived Cell-Free DNA of Patients with Primary Central Nervous System Lymphoma Obtained before Intracerebral Biopsy.
    Montesinos-Rongen M; Brunn A; Tuchscherer A; Borchmann P; Schorb E; Kasenda B; Altmüller J; Illerhaus G; Ruge MI; Maarouf M; Büttner R; Hansmann ML; Hallek M; Prinz M; Siebert R; Deckert M
    J Mol Diagn; 2020 Oct; 22(10):1300-1307. PubMed ID: 32745612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the genomic profiles of cell-free DNA between plasma, sputum, urine, and tumor tissue in advanced NSCLC.
    Wu Z; Yang Z; Li CS; Zhao W; Liang ZX; Dai Y; Zhu Q; Miao KL; Cui DH; Chen LA
    Cancer Med; 2019 Mar; 8(3):910-919. PubMed ID: 30767431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia.
    Poulain S; Roumier C; Venet-Caillault A; Figeac M; Herbaux C; Marot G; Doye E; Bertrand E; Geffroy S; Lepretre F; Nibourel O; Decambron A; Boyle EM; Renneville A; Tricot S; Daudignon A; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
    Clin Cancer Res; 2016 Mar; 22(6):1480-8. PubMed ID: 26490317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IQN path ASBL report from the first European cfDNA consensus meeting: expert opinion on the minimal requirements for clinical ctDNA testing.
    Deans ZC; Butler R; Cheetham M; Dequeker EMC; Fairley JA; Fenizia F; Hall JA; Keppens C; Normanno N; Schuuring E; Patton SJ
    Virchows Arch; 2019 Jun; 474(6):681-689. PubMed ID: 31028539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile cell‑free DNA as a novel and powerful liquid biopsy for detecting somatic variants in biliary tract cancer.
    Shen N; Zhang D; Yin L; Qiu Y; Liu J; Yu W; Fu X; Zhu B; Xu X; Duan A; Chen Z; Wang X; Cao X; Zhao T; Zhou Z; Yu L; Qin H; Fang Z; Li JY; Liu Y; Xiong L; Yuan B; Li F; Zhang Y
    Oncol Rep; 2019 Aug; 42(2):549-560. PubMed ID: 31173267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations found in cell-free DNAs of patients with malignant lymphoma at remission can derive from clonal hematopoiesis.
    Suehara Y; Sakata-Yanagimoto M; Hattori K; Kusakabe M; Nanmoku T; Sato T; Noguchi M; Chiba S
    Cancer Sci; 2019 Oct; 110(10):3375-3381. PubMed ID: 31436356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and prognostic impact of cell-free DNA in human cancers: Systematic review.
    Cervena K; Vodicka P; Vymetalkova V
    Mutat Res Rev Mutat Res; 2019; 781():100-129. PubMed ID: 31416571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of somatic mutations in patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance.
    Varettoni M; Zibellini S; Defrancesco I; Ferretti VV; Rizzo E; Malcovati L; Gallì A; Porta MGD; Boveri E; Arcaini L; Candido C; Paulli M; Cazzola M
    Haematologica; 2017 Dec; 102(12):2077-2085. PubMed ID: 28983055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple and cost-effective laboratory methods to evaluate and validate cell-free DNA isolation.
    Mojtabanezhad Shariatpanahi A; Rokni P; Shahabi E; Varshoee Tabrizi F; Kerachian MA
    BMC Res Notes; 2018 Oct; 11(1):757. PubMed ID: 30352614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liquid biopsy in extranodal NK/T-cell lymphoma: a prospective analysis of cell-free DNA genotyping and monitoring.
    Qi F; Cao Z; Chen B; Chai Y; Lin J; Ye J; Wei Y; Liu H; Han-Zhang H; Mao X; Feng X; Dong M
    Blood Adv; 2021 Jun; 5(11):2505-2514. PubMed ID: 34047776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-free DNA diagnostics: current and emerging applications in oncology.
    Muluhngwi P; Valdes R; Fernandez-Botran R; Burton E; Williams B; Linder MW
    Pharmacogenomics; 2019 Apr; 20(5):357-380. PubMed ID: 30983510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma cell dyscrasias and the head and neck.
    Batsakis JG; Medeiros JL; Luna MA; El-Naggar AK
    Ann Diagn Pathol; 2002 Apr; 6(2):129-40. PubMed ID: 12004363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.